| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/19/2008 | EP1513545B1 Methods and means to promote gut absorption |
| 03/19/2008 | EP1511751B1 Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects |
| 03/19/2008 | EP1453487B1 Pharmaceutical dosage form with multiple coatings |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1300141B1 Medical composition kit for treating lesioned abnormal tissue |
| 03/19/2008 | EP1246628A4 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP0971735B1 Methods and compositions for treating inflammatory bowel disease |
| 03/19/2008 | CN101144061A Yeast engineering bacterium for producing human pepsinogen and its preparation method and application |
| 03/19/2008 | CN101143892A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 03/19/2008 | CN101143217A Treatment of neurological and neuropsychological disorders |
| 03/19/2008 | CN101143215A Proteinase inhibitor nervous cell protecting function and application |
| 03/19/2008 | CN101143208A Sobering-up liver-protecting capsule and production method thereof |
| 03/19/2008 | CN101143203A Compound oral liquid with liver-protecting and stomach-nourishing function |
| 03/19/2008 | CN101143202A Compound oral administration preparation with protective function to chemical liver injury |
| 03/19/2008 | CN101143182A Traditional Chinese medicine for treating alcoholic cirrhosis |
| 03/19/2008 | CN101143178A Traditional Chinese medicine for treating late esophagus cancer |
| 03/19/2008 | CN101143173A Capsule for treating acute dysentery and acute diarrhea and its preparation method |
| 03/19/2008 | CN101143169A Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method |
| 03/19/2008 | CN101143159A Traditional Chinese medicine for treating toothache |
| 03/19/2008 | CN101143155A Double ginseng composition and its application |
| 03/19/2008 | CN101143152A Dripping pill for treating digestive ulcer and medicine composition containing the same |
| 03/19/2008 | CN101143143A Medicine for treating gastroesophageal reflux disease and functional dyspepsia |
| 03/19/2008 | CN101143142A Silybin supersaturated self-emulsion composition and preparation method thereof |
| 03/19/2008 | CN101143139A Stable tiopronin injection and preparation method thereof |
| 03/19/2008 | CN101143137A Gargle for treating toothache |
| 03/19/2008 | CN101142983A Cake capable of moistening intestine function and its making method |
| 03/19/2008 | CN100375786C Recombinant MVA capable of expressing structural HCV antigens |
| 03/19/2008 | CN100375629C Pilose antler-glossy ganoderma capsule |
| 03/19/2008 | CN100375620C Application of monomer ingredient jatrorrhizine of Chinese goldthread in preparation of medicine for enhancing stomach motility |
| 03/19/2008 | CN100375614C Dripping pills with jaundice eliminating liver protecting functions and its preparation method |
| 03/19/2008 | CN100375613C Schizandrol dripping pills for decreasing aminopherase and method for preparing the same |
| 03/19/2008 | CN100375611C Dripping pills of rheocamphoradin and its preparation process |
| 03/19/2008 | CN100375608C Tortoise-astragalus root-ginseng dripping pill and its preparing method |
| 03/18/2008 | US7345138 Biodegradable polyphosphates for controlled release of bioactive substances |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | US7345065 Using adrenergic receptors; side effect reduction |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345061 Alkylammonium salts of omeprazole and esomeprazole |
| 03/18/2008 | US7345059 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345041 Chemical compounds |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | US7344740 Methods and apparatus to prevent, treat, and cure the symptoms of nausea caused by chemotherapy treatments of human cancers |
| 03/18/2008 | US7344709 Administering interferon-beta (IFN- beta 9), after failed treatment with interferon- alpha |
| 03/18/2008 | CA2507743C Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 03/18/2008 | CA2394120C Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 03/18/2008 | CA2315927C Oral pharmaceutical pulsed release dosage form |
| 03/18/2008 | CA2275663C Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence |
| 03/18/2008 | CA2266645C Polycarboxylic based cross-linked copolymer |
| 03/18/2008 | CA2191213C Lactobacillus strains of human origin, their compositions and uses thereof |
| 03/13/2008 | WO2008031014A1 Method for reducing or alleviating inflammation in the digestive tract |
| 03/13/2008 | WO2008031013A1 Method for treating inflammatory diseases of the digestive tract |
| 03/13/2008 | WO2008030579A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 03/13/2008 | WO2008030382A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 03/13/2008 | WO2008030141A1 Use of nifuroxazide in the form of a component of a combined drug therapy for treating diseases associated with helicobacter pylori and a curing method for eradicating a causative agent |
| 03/13/2008 | WO2008029949A1 Method and composition for promoting gastrointestinal bicarbonate secretion |
| 03/13/2008 | WO2008029876A1 Salt of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and crystal thereof |
| 03/13/2008 | WO2008029846A1 Lipase inhibitor |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008028603A1 Oral and/or topical compositions |
| 03/13/2008 | WO2008028300A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 03/13/2008 | WO2007130820A3 Mglur5 modulators i |
| 03/13/2008 | WO2007082914A3 Method of diagnosis and method of treatment |
| 03/13/2008 | US20080064747 Prevention of Neutrophil Recruitment |
| 03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064717 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease; N-(3-chlorophenyl)-N'-(4'-{(R)-hydroxy[(1R,2R)-2-(hydroxymethyl)cyclopentyl]methyl}-1,1'-biphenyl-4-yl)urea |
| 03/13/2008 | US20080064688 Anti-inflammatory medicaments |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064629 Promoting DNA synthesis in and preventing death of hepatocytes; regenerating parenchyma |
| 03/13/2008 | US20080063726 Micronized fenofibrate; polyvinylpyrrolidone, polyvinyl alcohol, hydroxypropylcellulose hydrophilic polymer; sodium lauryl sulfate, monooleate, monolaurate, monopalmitate surfactant; starch, colloidal silica, cross-linked polyvinyl pyrrolidone inert hydrosoluble carrier particles; hypolipemiant |
| 03/13/2008 | US20080063666 New lactic bacteria useful as probiotics |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063631 prophylaxis of vascular system disorders in mammals by administering apoptotic cells and/or bodies derived from leukocytes or lymphocytes |
| 03/13/2008 | CA2663091A1 Modulators of interleukin-1 receptor-associated kinase |
| 03/13/2008 | CA2662710A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 03/13/2008 | CA2662535A1 Method for reducing or alleviating inflammation in the digestive tract |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2661404A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897877A2 Process for producing crystal |
| 03/12/2008 | EP1897558A1 Solid preparation |
| 03/12/2008 | EP1897449A1 Oral and /or topical compositions |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896489A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 03/12/2008 | EP1896471A1 Imidazopyridine derivatives as acid pump antagonists |
| 03/12/2008 | EP1896427A2 Novel 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 03/12/2008 | EP1896134A2 Methods and compositions for treating degenerative bone disorders |
| 03/12/2008 | EP1896035A2 Carbazole formulations for the treatment of psoriasis and angiogenesis |
| 03/12/2008 | EP1895996A1 Formulation for prophylaxis of oral cavity diseases |
| 03/12/2008 | EP1895987A2 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |